Peer Review History
| Original SubmissionFebruary 3, 2021 |
|---|
|
Transfer Alert
This paper was transferred from another journal. As a result, its full editorial history (including decision letters, peer reviews and author responses) may not be present.
PONE-D-21-03741 “If I've got latent TB, I would like to get rid of it”: Derivation of the CARD (Constraints, Actions, Risks, and Desires) Framework informed by South African healthcare worker perspectives on latent tuberculosis treatment PLOS ONE Dear Dr. Nathavitharana, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by May 02 2021 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols We look forward to receiving your revised manuscript. Kind regards, Amrita Daftary Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. Please include a copy of the interview guides used as a Supporting Information file. 3. We note that you have indicated that data from this study are available upon request. PLOS only allows data to be available upon request if there are legal or ethical restrictions on sharing data publicly. For information on unacceptable data access restrictions, please see http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions. In your revised cover letter, please address the following prompts: a) If there are ethical or legal restrictions on sharing a de-identified data set, please explain them in detail (e.g., data contain potentially identifying or sensitive patient information) and who has imposed them (e.g., an ethics committee). Please also provide contact information for a data access committee, ethics committee, or other institutional body to which data requests may be sent. b) If there are no restrictions, please upload the minimal anonymized data set necessary to replicate your study findings as either Supporting Information files or to a stable, public repository and provide us with the relevant URLs, DOIs, or accession numbers. Please see http://www.bmj.com/content/340/bmj.c181.long for guidelines on how to de-identify and prepare clinical data for publication. For a list of acceptable repositories, please see http://journals.plos.org/plosone/s/data-availability#loc-recommended-repositories. We will update your Data Availability statement on your behalf to reflect the information you provide. 4. Please amend the manuscript submission data (via Edit Submission) to include authors Ananja van der Westhuizen, Helene-Mari van der Westhuizen, Hridesh Mishra, Annalean Sampson, Jack Meintjes, Edward Nardell, Andrew McDowell, Grant Theron. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: reviewer 1 comments are in attachments. Reviewer 2 comments are pasted below. Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: Partly ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: N/A Reviewer #2: N/A ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: No Reviewer #2: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: Complete review has been attached The author has not made the data underlying the findings fully available, due to participant narrations in transcripts potentially jeopardizing their anonymity. The manuscript has been written in an intelligible fashion and in standard English, but some sentences require minor restructuring. Reviewer #2: This qualitative research study looks at clinician perceptions of occupational health risk of TB infection (LTBI) and disease and the use of TB preventive therapy (TPT) at a teaching hospital in Cape Town, South Africa. The subject is of primary importance, as risk of TB infection and disease is high in this setting, and health workers are at twice the risk compared to the general population given their routine exposure. Based on 22 in-depth interviews with nurses and doctors with both positive and negative LTBI results across 5 hospital departments, the authors make a number of conclusions, most notably, that knowing LTBI status may provide the impetus for clinicians to take TPT and that system-level constraints may prevent this from coming to fruition. In addition, the authors present a unified framework that encourages the consideration of systemic barriers and facilitators in the uptake of interventions among health workers of use to future researchers. The manuscript is very well organised and written, and findings provide important evidence to advocate for routine TB screening and prophylaxis in high-burden clinical settings. There are some concerns with the certainty with which the authors present the findings and the presence of bias toward TPT implementation at all cost, which can be tempered with some additions and revisions to the findings and discussion sections. Major suggestions are as follows: The methods would benefit from additional information on the authors who conducted the analysis. It should be clear to readers that data is viewed from a biomedical perspective where TPT is of benefit. I would caution the authors to shy away from definitive statements around the findings. For example “we demonstrate that LTBI testing and treatment are acceptable and desirable to HWs” (Line 442-443); “CARD analysis demonstrated that HWs have a strong desire to prevent themselves from developing TB” (line 453-4) and discussing what “the majority” of health workers reported with regard to TPT willingness in the study, as these statements misrepresent what can be concluded based on a very small set of data. Qualitative research is intended to provide a deeper understanding of a phenomenon, often from multiple perspectives, not to draw far reaching conclusions for the broader population from which the sample was drawn. The wording around these findings should be softened to reflect the study design. It can be helpful to intersperse limitations within the discussion, as relevant, rather than leaving these for a section at the end, as is typically done in quantitative research. It may also help to touch on the transferability of findings (as opposed to generalisability – line 492), so as not to miss the importance of what has been found. The authors present a lot of rich data on barriers and facilitators, some of which is not adequately discussed. Table 1 contains a lot of information, some of which is not presented in text (e.g. stigma) and some for which solutions are oversimplified (e.g. senior physicians should model use of PPE). Rather than try to tackle all of these data in one paper/table, it may be more suitable to discuss the main findings (e.g. knowing LTBI status may improve TPT uptake among HWs) in-depth, while acknowledging the complexity of other factors, and how they might affect uptake. The authors must be cautious not to confuse complex concerns with “training gaps” or “gaps in latent TB understanding.” This displays a bias toward TPT-use without considering the genuine concerns and lived experience of clinicians in this setting. For example: As TB is endemic and comparatively harder to catch than COVID, it may not be realistic to expect doctors and nurses to wear PPE all the time, especially for those who are also at a high risk outside the hospital environment. It is important to acknowledge that there are real limitations to current infection control practices in this setting, and suggests we need better long-term solutions. This could make TPT even more attractive as an intervention at the institution level. Re-exposure is also a reality in this setting. We don’t fully understand how TPT may affect innate immunity, and this concerns some of the clinical staff. It is important to acknowledge these concerns which suggest that not all HWs will opt for TPT until better evidence is available. Similarly, side effects of the regimen are a concern, regardless of whether it is IPT, 3HP, or some other regimen. Nurses especially would be familiar with the hardships of side effects based on patient experience. Other research has suggested that this prevents health workers and patients from opting for prophylaxis, which may limit uptake. It would also be helpful to readers from outside LMICs to provide some context around cost concerns. What does a TB ward look like? Are negative pressure rooms available? What other competing risks to patients and HWs are present? How might we go about advocating for systemic changes to prevent TB and other nosocomial infections in light of limited resources? Minor comments: Introduction: There are a lot of acronyms introduced that may be unfamiliar to readers outside the field of TB. I would suggest spelling out infection control and Tygerberg hospital to reduce the number of acronyms. Line 94: Please reword this sentence, as hypothesis testing is not appropriate for qualitative data, as the findings are inductively derived. Methods: Was a particular methodological orientation used in this study (e.g. ethnography, grounded theory)? Line 144: Who was the interview guide pilot tested on, and were any revisions made? It would be helpful to share the interview guide in a supplement. In particular it would be interesting to note in the findings whether any of the interviewees had previously had TB or lost a colleague to TB. Information on gender of participants should be included in methods or findings. Lines 164: This section intersperses a lot of findings in the methods. Perhaps this detail would be better shared as a table or graph in the beginning of findings. I leave this to the authors to decide. Line 167: It would be helpful to add a line or two explaining a network approach for those who are unfamiliar. Lines 172-174: this sentence was a bit confusing and could benefit from rewording. Lines 184-85: Is it relevant that these data were analysed in parallel with SAFE study results? Did one inform the other? Findings: Lines 374-377: This sentence is long and difficult to follow. Please consider rewording. Discussion: Lines 438-439: I would advise rewording this sentence, as this is not the first study to look at perceptions of TPT in HWs in a high-incidence setting; however, the findings are very relevant. Lines 499-501: This is a very important finding and a strength of your approach. ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: Yes: Jody Boffa [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.
|
| Revision 1 |
|
“If I've got latent TB, I would like to get rid of it”: Derivation of the CARD (Constraints, Actions, Risks, and Desires) Framework informed by South African healthcare worker perspectives on latent tuberculosis treatment PONE-D-21-03741R1 Dear Dr. Nathavitharana, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Amrita Daftary Academic Editor PLOS ONE Additional Editor Comments (optional): Reviewers' comments: |
| Formally Accepted |
|
PONE-D-21-03741R1 “If I've got latent TB, I would like to get rid of it”: Derivation of the CARD (Constraints, Actions, Risks, and Desires) Framework informed by South African healthcare worker perspectives on latent tuberculosis treatment Dear Dr. Nathavitharana: I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department. If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org. If we can help with anything else, please email us at plosone@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Amrita Daftary Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .